Arthritis, Psoriatic

Psoriatic Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to NSAIDs or Non-biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) Therapy
NCT01490450 | PHASE 2 | INTERVENTIONAL

The purpose of this study is to characterize the safety, efficacy and dose response of BMS-945429 in subjects with active Psoriatic Arthritis and an inadequate response to Nonsteroidal anti-inflammatory drugs (NSAIDs) and non-biologic Disease modifying anti-rheumatic drugs (DMARDs).

Trial Information
49 Sites
165 Participants
Recruiting
18 Years to 75 Years

If interested, contact clinicaltrials@cslbehring.com for more information

CSL Behring respects your privacy. For an explanation of how CSL Behring will use the information you are submitting, please view our Privacy Policy

SUBMIT
San Diego Arthritis Medical Clinic
San Diego,California,United States,92108
Denver Arthritis Clinic
Denver,Colorado,United States,80230
New England Research Associates, Llc
Trumbull,Connecticut,United States,06611
Sarasota Arthritis Research Center
Sarasota,Florida,United States,34239
Arthritis Associates Of Mississippi
Jackson,Mississippi,United States,39202
Box Arthritis And Rheumatology Of The Carolinas, Pllc
Charlotte,North Carolina,United States,28210
Health Research Of Oklahoma
Oklahoma City,Oklahoma,United States,73103
East Penn Rheumatology Associates, P.C.
Bethlehem,Pennsylvania,United States,18015
Local Institution
Capital Federal,Buenos Aires,Argentina,1015
Local Institution
Capital Federal,Buenos Aires,Argentina,1425
Local Institution
Capital Federal,Buenos Aires,Argentina,1428
Local Institution
Tucuman,Argentina,4000
Local Institution
Cairns,Queensland,Australia,4870
Local Institution
Maroochydore,Queensland,Australia,4558
Local Institution
Woodville,South Australia,Australia,5011
Local Institution
Shenton Park,Western Australia,Australia,6008
Manitoba Clinic
Winnipeg,Manitoba,Canada,R3A1M3
Local Institution
Montreal,Quebec,Canada,H2L1S6
Centre De Rhumatologie De L Est Du Quebec
Rimouski,Quebec,Canada,G5L8W1
Centre De Recherche MusculoSquelettique
Trois-rivieres,Quebec,Canada,G8Z1Y2
Local Institution
Pardubice,Czechia,53002
Local Institution
Praha 2,Czechia,12850
Local Institution
Bad Nauheim,Germany,61231
Local Institution
Erlangen,Germany,91054
Local Institution
Planegg,Germany,82152
Local Institution
Budapest,Hungary,1023
Local Institution
Budapest,Hungary,1062
Local Institution
Debrecen,Hungary,4012
Local Institution
Veszprem,Hungary,8200
Local Institution
Firenze,Italy,50139
Local Institution
Napoli,Italy,80131
Local Institution
Mexico,Aguascalientes,Mexico,20127
Local Institution
Zapopan,Jalisco,Mexico,45190
Local Institution
Monterrey,Nuevo Leon,Mexico,64460
Local Institution
Bialystok,Poland,15-351
Local Institution
Dabrowka,Poland,62-069
Local Institution
Elblag,Poland,82-300
Local Institution
Poznan,Poland,60773
Local Institution
Warszawa,Poland,01-868
Local Institution
Moscow,Russian Federation,115522
Local Institution
Yaroslavl,Russian Federation,150003
Local Institution
Pretoria,Gauteng,South Africa,0083
Local Institution
Pretoria,Gauteng,South Africa,0084
Local Institution
Durban,KWA ZULU Natal,South Africa,4001
Local Institution
Panorama, Cape Town,Western CAPE,South Africa,7500
Local Institution
Pinelands, Cape Town,Western Cape,South Africa,7405
Local Institution
A Coruna,Spain,15006
Local Institution
Barcelona,Spain,08036
Local Institution
Sevilla,Spain,41071

Study Eligibility Criteria

Additional Studies

Additional studies can be found at ClinicalTrials.gov